Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-31

Clinical Trial Update: An Open Label Trial to Decrease Signs and Symptoms of Orthostatic Hypotension Using Midodrine or Intravenous Fluid Bolus in Patients Following Total Hip Arthroplasty [NA]

View source ↗

Summary

An open-label, terminated clinical trial evaluating midodrine versus intravenous fluid bolus to reduce signs and symptoms of orthostatic hypotension after total…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Midodrine (Midodrine)
  • Normal Saline (sodium chloride 0.9% solution)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Orthostatic Hypotension | NA | Status: TERMINATED | Results posted: 2017-07-31